Previous 10 | Next 10 |
2023-06-29 05:02:34 ET For further details see: Goldman adds 39 new stocks to its Sharpe Ratio basket with megacaps absent
Second annual report highlights company’s advancements with a focus on innovation and access to ensure a healthier, more sustainable future for women worldwide. Organon (NYSE: OGN), a global healthcare company focused on women’s health, today released its 2022-2023 Envir...
2023-06-08 12:39:22 ET Summary The article discusses leverage ratios such as debt to assets, debt to equity, debt to EBITDA, and debt to free cash flow, as well as the interest coverage ratio. Using company examples, I explain various definitions, when the individual metrics are b...
Agreement is part of a transformative model convening governments, global development banks and other multilateral agencies to use results-based financing to improve the lives of women Today, Organon (NYSE:OGN), a global healthcare company focused on women’s health, and CAF, ...
2023-06-07 07:00:00 ET Summary Markets overreacted to Norwich suing the FDA. Investors must consider recently reported weak Q1 results of Bausch Health. Reasons BHC stock is a buy from here. Last summer, Bausch Health ( BHC ) traded with wild 11% drops . Vola...
ORGANON CANADA TO SUPPORT LE CHAÎNON BY FUNDING THE INITIAL CONSTRUCTION PHASE OF ITS MEDICAL CLINIC Canada NewsWire The project aims to facilitate access for Le Chaînon residents to medical consultations KIRKLAND, QC , May 18, 2023 /CNW/ - As p...
2023-05-08 11:41:03 ET Summary The share price of Organon & Co. has taken a dramatic tumble after reporting quarters with sluggish revenue and earnings numbers. The dividend is holding at about a 5% yield and its safety seems of only slight concern because the company has stro...
2023-05-04 14:28:38 ET Summary Organon reported obviously disappointing results today - OGN stock plunged more than 10% in response. In this update, I share my view on Organon's quarterly results and point out possible warning signs and reasons for the sell-off. I give an upda...
2023-05-04 12:05:35 ET Organon ( NYSE: OGN ) stock fell ~10% on Thursday after Q1 results. Adjusted EPS fell -34.5% Y/Y to $1.08 and also missed analysts' estimates. Revenue declined -1.8% Y/Y to ~$1.54B, but came in line with expectations. Excluding the impact of f...
2023-05-04 11:04:08 ET Organon & Co. (OGN) Q1 2023 Earnings Conference Call May 04, 2023 08:30 A.M. ET Company Participants Jennifer Halchak - VP, IR Kevin Ali - CEO Matthew Walsh - CFO Conference Call Participants Unidentified Analyst - Evercore ...
News, Short Squeeze, Breakout and More Instantly...
VANCOUVER, BC / ACCESSWIRE / July 31, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce a new significant gold-silver discovery, called the Navidad vein system, on the Ermitaño Mine concessions in Sonora, Mexico where the Company holds a...
VANCOUVER, BC / ACCESSWIRE / July 24, 2024 / (TSXV:OGN)(OTCQX:OGNRF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce updates for its partner funded exploration stage projects and royalties. Highlights Estimated 30,000 metres of drilling in seven planned or comp...
Company estimates $15 million of milestone expense in the second quarter Organon (NYSE: OGN), a global healthcare company with a focus on women’s health, will release its second quarter 2024 financial results on August 6, 2024, prior to the company’s webcast and conference...